JPRN-UMIN000001086已完成未知
Effect of antiplatlet treatment on arterial elasticity - TRIS(Trial of HMG-CoA Reductase Inhibitor for atheroSclerosis)
Tohoku University Graduate School of Medicine, Division of Molecular Metabolism and Diabetes0 个研究点目标入组 50 人开始时间: 2008年3月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •severe liver dysfunction severe renal dysfunction familial hypercholesterolemia severe retinopathy severe vascular disease with urgent treatment HbA1c over 9% blood pressure over 180/100 mmHg
研究者
相似试验
已完成
不适用
Effect of antiplatlet treatment on arterial elasticitytype2 diabetes with central vascular diseaseJPRN-UMIN000001084Tohoku University Graduate School of Medicine50
进行中（未招募）
不适用
Comparison between standard clopidogrel therapy and low dose of prasugrel in elderly patients.EUCTR2013-000631-27-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
已完成
不适用
Antiplatelet therapy following peripheral endovascular interventioPeripheral arterial diseaseCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12618000523202Aneurin Bevan University Health Board516
未知
不适用
Vascular function and Antiplatelet effects on switching from Clopidgrel to Prasugrel in chronic phase after percutaneous coronary interventioThe patients on DAPT after PCI who underwent follow-up coronary angiographyJPRN-UMIN000023756Department of Cardiovascular Medicine,Dokkyo Medical University100
已完成
3 期
The Effect of Drug on the Patency Rate of Fistulaechoronic renal failure.End-stage renal diseaseIRCT201009292220N3Vice-Chancellor for Research, Shahid Beheshti University of Medical Sciences501